Solanezumab Recent News
Eli Lilly Plunges 15% After Alzheimer's Study Fails To Meet Goals
New Upside Potential Drives JPMorgan's Eli Lilly Upgrade
The Heart Of Major Pharma Q1 Earnings Season: Eli Lilly, AbbVie, Bristol-Myers
Biotech Conference Suggests Tempering Expectations For Eli Lilly Drug
Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY)
Stocks Paul Ryan Would Pick
Jefferies Maintains Underperform on Eli Lilly